Rice Hall James & Associates’s MiMedx Group MDXG Stock Holding History

Rice Hall James & Associates’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-135,878	Closed	-$1.71M	–	301
2017 Q4	$1.71M	Sell	135,878 -7,079	-5%	-$86.3K	0.07%	226
2017 Q3	$1.7M	Sell	142,957 -52,817	-27%	-$783K	0.08%	211
2017 Q2	$2.93M	Sell	195,774 -119,851	-38%	-$1.6M	0.13%	119
2017 Q1	$3.01M	Sell	315,625 -8,700	-3%	-$73.5K	0.15%	114
2016 Q4	$2.87M	Sell	324,325 -350	-0.1%	-$3.15K	0.14%	124
2016 Q3	$2.79M	Buy	324,675 +117,700	+57%	+$932K	0.15%	129
2016 Q2	$1.65M	Buy	+206,975	New	+$1.61M	0.1%	199

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rice Hall James & Associates's MDXG Position: Q1 2018 in Review

Rice Hall James & Associates sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 135,878 shares — an estimated $1.71M sold.

Rice Hall James & Associates first reported a position in MDXG in Q2 2016 and held it in 7 quarters. The position peaked at $3.01M in Q1 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

Rice Hall James & Associates reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
Rice Hall James & Associates sold 135,878 MiMedx Group shares in Q1 2018, an estimated $1.71M.
Rice Hall James & Associates first reported a position in MiMedx Group in Q2 2016 and held it in 7 quarters.
Rice Hall James & Associates's MiMedx Group position peaked at $3.01M in Q1 2017.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on Rice Hall James & Associates's 13F filing for Q1 2018, filed 25 Apr 2018.